These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39393275)
1. METTL14 downregulates GLUT9 through m6A methylation and attenuates hyperuricemia-induced fibrosis in mouse renal tubular epithelial cells. Yang J; Jiang T; Lu X; Li X; Zhou X; Guo X; Ma C; Xie X; Li D; Yu S; An J; Zhao B; Li H Int Immunopharmacol; 2024 Dec; 143(Pt 1):113308. PubMed ID: 39393275 [TBL] [Abstract][Full Text] [Related]
2. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway. Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255 [TBL] [Abstract][Full Text] [Related]
3. Fasudil attenuates oxidative stress-induced partial epithelial-mesenchymal transition of tubular epithelial cells in hyperuricemic nephropathy via activating Nrf2. Cao Y; Wang Y; Li W; Feng J; Chen Y; Chen R; Hu L; Wei J Eur J Pharmacol; 2024 Jul; 975():176640. PubMed ID: 38750716 [TBL] [Abstract][Full Text] [Related]
4. METTL14 aggravates podocyte injury and glomerulopathy progression through N Lu Z; Liu H; Song N; Liang Y; Zhu J; Chen J; Ning Y; Hu J; Fang Y; Teng J; Zou J; Dai Y; Ding X Cell Death Dis; 2021 Sep; 12(10):881. PubMed ID: 34580283 [TBL] [Abstract][Full Text] [Related]
5. METTL14-Mediated m6A Modification of Gu X; Song Y; Liu X; Cheng Z; Min J; Zhang Y Front Biosci (Landmark Ed); 2024 Aug; 29(8):298. PubMed ID: 39206905 [TBL] [Abstract][Full Text] [Related]
6. Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling. Ren Q; Tao S; Guo F; Wang B; Yang L; Ma L; Fu P Phytomedicine; 2021 Jul; 87():153552. PubMed ID: 33994251 [TBL] [Abstract][Full Text] [Related]
7. Regulation of renal ischemia-reperfusion injury and tubular epithelial cell ferroptosis by pparγ m6a methylation: mechanisms and therapeutic implications. Liu W; Xiong Z; Fu T; Yang J; Zou J; Wu Y; Kuang L; Wang Q; Li S; Le A Biol Direct; 2024 Oct; 19(1):99. PubMed ID: 39444036 [TBL] [Abstract][Full Text] [Related]
8. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Cui D; Liu S; Tang M; Lu Y; Zhao M; Mao R; Wang C; Yuan Y; Li L; Chen Y; Cheng J; Lu Y; Liu J Phytomedicine; 2020 Jan; 66():153111. PubMed ID: 31790902 [TBL] [Abstract][Full Text] [Related]
9. The impact of chrysanthemi indici flos-enriched flavonoid part on the model of hyperuricemia based on inhibiting synthesis and promoting excretion of uric acid. Jiao L; Wang R; Dong Y; Su J; Yu J; Yan M; Chen S; Lv G J Ethnopharmacol; 2024 Oct; 333():118488. PubMed ID: 38925319 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy. Shi M; Guo F; Liao D; Huang R; Feng Y; Zeng X; Ma L; Fu P Eur J Pharmacol; 2020 Nov; 887():173570. PubMed ID: 32949603 [TBL] [Abstract][Full Text] [Related]
11. METTL14-mediated N Liu Z; Sun T; Piao C; Zhang Z; Kong C Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660 [TBL] [Abstract][Full Text] [Related]
12. METTL14 promotes chondrocyte ferroptosis in osteoarthritis via m6A modification of GPX4. Liu D; Ren L; Liu J Int J Rheum Dis; 2024 Aug; 27(8):e15297. PubMed ID: 39175261 [TBL] [Abstract][Full Text] [Related]
13. METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho. Li M; Deng L; Xu G Mol Med; 2021 Sep; 27(1):106. PubMed ID: 34503454 [TBL] [Abstract][Full Text] [Related]
14. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase. Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645 [TBL] [Abstract][Full Text] [Related]
15. The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy. Hu H; Li W; Hao Y; Peng Z; Zou Z; Wei J; Zhou Y; Liang W; Cao Y Cell Rep Med; 2024 Aug; 5(8):101690. PubMed ID: 39168099 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol, a novel inhibitor of GLUT9, ameliorates liver and kidney injuries in a D-galactose-induced ageing mouse model Li L; Li Y; Luo J; Jiang Y; Zhao Z; Chen Y; Huang Q; Zhang L; Wu T; Pang J Food Funct; 2021 Sep; 12(18):8274-8287. PubMed ID: 34180933 [TBL] [Abstract][Full Text] [Related]
17. The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1. Xu Y; Yuan XD; Wu JJ; Chen RY; Xia L; Zhang M; Han CH; Mou S J Cell Biochem; 2020 Jan; 121(1):524-533. PubMed ID: 31318098 [TBL] [Abstract][Full Text] [Related]
18. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762 [TBL] [Abstract][Full Text] [Related]
19. SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney. Auberson M; Stadelmann S; Stoudmann C; Seuwen K; Koesters R; Thorens B; Bonny O Pflugers Arch; 2018 Dec; 470(12):1739-1751. PubMed ID: 30105595 [TBL] [Abstract][Full Text] [Related]
20. METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease. Xu Z; Jia K; Wang H; Gao F; Zhao S; Li F; Hao J Cell Death Dis; 2021 Jan; 12(1):32. PubMed ID: 33414476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]